Consonance Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Consonance Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-311,234	Closed	-$47.9M	–	25
2014 Q3	$47.9M	Sell	311,234 -67,138	-18%	-$10.1M	6.57%	3
2014 Q2	$53.1M	Buy	378,372 +103,140	+37%	+$11.4M	7.89%	3
2014 Q1	$30.6M	Buy	275,232 +11,500	+4%	+$1.25M	4.55%	10
2013 Q4	$26.1M	Buy	263,732 +3,649	+1%	+$316K	4.28%	9
2013 Q3	$19.8M	Buy	260,083 +125,884	+94%	+$8.17M	4.94%	8
2013 Q2	$7.5M	Buy	+134,199	New	+$7.93M	2.67%	14

Other funds holding TARO

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Consonance Capital Management's TARO Position: Q4 2014 in Review

Consonance Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2014, closing a stake of 311,234 shares — an estimated $47.9M sold.

Consonance Capital Management first reported a position in TARO in Q2 2013 and held it in 6 quarters. The position peaked at $53.1M in Q2 2014. 89 funds tracked by Wall St. Rank hold TARO as of Q4 2014.

Consonance Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2014 after selling out during the quarter.
Consonance Capital Management sold 311,234 Taro Pharmaceutical Industries Ltd. shares in Q4 2014, an estimated $47.9M.
Consonance Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 6 quarters.
Consonance Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $53.1M in Q2 2014.
89 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2014.

Based on Consonance Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.